BDH Industries Ltd
Incorporated in 1935, BDH Industries Ltd manufactures therapeutic formulations covering wide range of pharmaceuticals[1]
- Market Cap ₹ 205 Cr.
- Current Price ₹ 356
- High / Low ₹ 524 / 253
- Stock P/E 19.0
- Book Value ₹ 134
- Dividend Yield 1.26 %
- ROCE 20.5 %
- ROE 14.8 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has been maintaining a healthy dividend payout of 27.0%
Cons
- The company has delivered a poor sales growth of 10.8% over past five years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 44 | 46 | 43 | 41 | 52 | 59 | 57 | 69 | 74 | 86 | 67 | 96 | |
| 40 | 42 | 38 | 36 | 45 | 51 | 49 | 60 | 64 | 73 | 55 | 82 | |
| Operating Profit | 4 | 4 | 5 | 5 | 7 | 9 | 9 | 9 | 11 | 12 | 12 | 14 |
| OPM % | 9% | 9% | 11% | 13% | 14% | 15% | 15% | 13% | 15% | 14% | 17% | 14% |
| 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 4 | 5 | 5 | 5 | 7 | 8 | 9 | 10 | 11 | 13 | 12 | 15 |
| Tax % | 32% | 33% | 33% | 27% | 26% | 27% | 27% | 24% | 26% | 25% | 26% | 29% |
| 3 | 3 | 3 | 4 | 5 | 6 | 6 | 7 | 8 | 10 | 9 | 11 | |
| EPS in Rs | 4.46 | 5.61 | 5.80 | 6.53 | 8.39 | 10.32 | 11.05 | 12.54 | 14.24 | 17.14 | 16.10 | 18.78 |
| Dividend Payout % | 39% | 37% | 36% | 36% | 34% | 25% | 28% | 29% | 28% | 26% | 28% | 27% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 11% |
| 3 Years: | 9% |
| TTM: | 44% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 11% |
| 3 Years: | 10% |
| TTM: | 17% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 27% |
| 3 Years: | 35% |
| 1 Year: | 40% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 15% |
| 3 Years: | 15% |
| Last Year: | 15% |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| Reserves | 18 | 21 | 23 | 25 | 28 | 32 | 37 | 43 | 49 | 56 | 63 | 71 |
| 9 | 9 | 8 | 8 | 13 | 9 | 9 | 2 | 5 | 9 | 1 | 2 | |
| 19 | 15 | 17 | 18 | 18 | 18 | 19 | 18 | 20 | 23 | 17 | 20 | |
| Total Liabilities | 52 | 52 | 54 | 57 | 66 | 65 | 71 | 69 | 80 | 93 | 87 | 99 |
| 13 | 13 | 23 | 23 | 22 | 21 | 20 | 20 | 19 | 20 | 20 | 19 | |
| CWIP | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 38 | 35 | 31 | 34 | 44 | 44 | 51 | 49 | 61 | 73 | 67 | 80 | |
| Total Assets | 52 | 52 | 54 | 57 | 66 | 65 | 71 | 69 | 80 | 93 | 87 | 99 |
Cash Flows
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6 | 4 | 7 | -0 | -4 | 11 | 1 | 3 | 6 | -2 | 15 | -2 | |
| -0 | -5 | -5 | 0 | 1 | 1 | 1 | 1 | 0 | -0 | 2 | 2 | |
| -3 | -1 | -3 | -3 | 3 | -6 | -2 | -8 | 0 | 1 | -10 | -2 | |
| Net Cash Flow | 3 | -1 | -1 | -2 | 0 | 6 | -0 | -4 | 7 | -1 | 6 | -2 |
| Free Cash Flow | 6 | -0 | 1 | -1 | -4 | 11 | 1 | 4 | 6 | -4 | 15 | -2 |
| CFO/OP | 198% | 146% | 186% | 21% | -24% | 153% | 35% | 64% | 82% | 11% | 153% | 8% |
Ratios
Figures in Rs. Crores
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 81 | 64 | 67 | 63 | 89 | 68 | 96 | 76 | 82 | 121 | 78 | 120 |
| Inventory Days | 71 | 61 | 39 | 95 | 89 | 51 | 53 | 50 | 53 | 30 | 65 | 28 |
| Days Payable | 201 | 162 | 192 | 244 | 188 | 158 | 171 | 123 | 139 | 128 | 134 | 91 |
| Cash Conversion Cycle | -49 | -37 | -85 | -85 | -10 | -39 | -21 | 4 | -5 | 23 | 9 | 58 |
| Working Capital Days | -76 | -72 | -90 | -60 | -29 | -31 | 6 | 56 | 49 | 71 | 102 | 116 |
| ROCE % | 13% | 15% | 14% | 14% | 16% | 19% | 18% | 18% | 20% | 21% | 18% | 20% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Domestic Revenue ₹ In Lakhs |
|
|||||||||||
| Export Revenue ₹ In Lakhs |
||||||||||||
| Number of Employees Number |
||||||||||||
| Installed Wind Power Capacity MW |
||||||||||||
| Electrical Energy Generated (Wind) kWh |
||||||||||||
| Gross Current Asset (GCA) Days Days |
||||||||||||
| R&D Expenditure (Percentage of Turnover) % |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
28 May - BDH Industries filed its Annual Secretarial Compliance Report for year ended 31 March 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
23 May - We are enclosing herewith the Audited Standalone Financial Results for the quarter and year ended on 31st March 2026 of the financial year 2025-26 published …
-
Announcement under Regulation 30 (LODR)-Meeting Updates
21 May - Board approved FY26 audited results, recommended Rs5 dividend, set AGM for 14 Aug 2026, and reported unmodified audit opinion.
-
Corporate Action-Board approves Dividend
21 May - Board approved FY26 audited results, recommended Rs.5 dividend, fixed 14 Aug 2026 AGM, appointed auditors.
- Audited Standalone Financial Results For The Fourth Quarter And Year Ended On 31St March 2026 Of The Financial Year 2025-26. 21 May
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
BDHIL is a full-service Contract Manufacturing Organization for production of Pharmaceutical, Oncological Products and associated packaging services. It is an exporter and manufacturer of therapeutic formulations covering a wide range of pharmaceuticals